Immunoglobulin replacement therapy in secondary hypogammaglobulinemia [PDF]
Frontiers in Immunology, 2014 Immunoglobulin (Ig) replacement therapy dramatically changed the clinical course of primary hypogammaglobulinemias, significantly reducing the incidence of infectious events.
Nicolò eCompagno +3 more
doaj +3 more sources
Primary Immune Deficiency: Patients’ Preferences for Replacement Immunoglobulin Therapy [PDF]
Frontiers in Immunology, 2022 PurposeImmunoglobulin (Ig) replacement therapy is an important life-saving treatment modality for patients with primary antibody immune deficiency disorders (PAD).
Juan Marcos Gonzalez +4 more
doaj +4 more sources
Immunoglobulin replacement therapies in inborn errors of immunity: a review
Frontiers in PediatricsImmunoglobulins (Ig) were used as a therapeutic modality for the first time in a patient with X-linked agammaglobulinemia in 1952 by Colonel Ogden Bruton, decades before the molecular mechanisms causing the disease were unraveled.
Archan Sil +7 more
doaj +3 more sources
Immunoglobulin Replacement Therapy: Insights into Multiple Myeloma Management. [PDF]
Cancers (Basel)Immunoglobulin (Ig) replacement therapy (IgRT) consists of the administration of low-dose human polyclonal Igs for the treatment of primary and secondary hypogammaglobulinemia that are associated with recurrent infections and immune dysfunction. IgRT restores physiological antibody levels and induces an immunomodulatory effect by strengthening immune ...
Saltarella I +7 more
europepmc +4 more sources
Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia. [PDF]
Bone Marrow Transplant, 2022 The efficacy of immunoglobulin replacement therapy (IgRT) has been demonstrated for primary immune deficiency diseases and hematological malignancies such as chronic lymphocytic leukemia (CLL) or multiple myeloma with hypogammaglobulinemia. Clinical development of anti-B cell therapies including a monoclonal antibody, bispecific antibody, or chimeric ...
Ohmoto A +4 more
europepmc +3 more sources
Immunoglobulin Replacement Therapy in Children [PDF]
Immunology and Allergy Clinics of North America, 2008 The benefit of immunoglobulin (IG) replacement in primary antibody deficiencies is unquestionable. Many of these congenital disorders present early in life and this therapy is often first implemented in the young. This article focuses on the indications of IG replacement in children, with an emphasis on the specific diagnostic problems encountered in ...
Maria, Garcia-Lloret +2 more
openaire +2 more sources
Treatment of patients with immunodeficiency: Medication, gene therapy, and transplantation
Jornal de Pediatria, 2021 Objectives: To provide an overview of drug treatment, transplantation, and gene therapy for patients with primary immunodeficiencies. Source of data: Non-systematic review of the literature in the English language carried out at PubMed. Synthesis of data:
Gesmar Rodrigues Silva Segundo +1 more
doaj +1 more source
Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for Difficult-To-Treat Chronic Hepatitis E [PDF]
, 2020 Hepatitis E virus (HEV) infection is an emerging disease in industrialized countries which is usually characterized by a self-limited course. However, there is an increased risk of HEV persistence in immunocompromised risk populations, comprising ...
Biedermann, Paula +7 more
core +1 more source
Subcutaneous IgG Replacement Therapy by Push in 32 Patients with Primary Immunodeficiency Diseases in Argentine [PDF]
, 2014 Introduction: Regular replacement with immunoglobulin infusions is the mainstay of treatment in the majority of primary immunodeficiencies. Several studies showed that Subcutaneous Immunoglobulin (SCIG) has similar efficacy to Intravenous Immunoglobulin (
Bezrodnik, Liliana +6 more
core +1 more source
Immunoglobulin replacement therapy for yellow nail syndrome [PDF]
Scandinavian Journal of Immunology, 2018 Immunoglobulin replacement therapy for yellow nail ...
Lo Conte, C. +8 more
openaire +5 more sources